Method of treatment for multiple sclerosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514903, A61K 3144

Patent

active

049944665

ABSTRACT:
A method of treating a patient suffering from multiple sclerosis comprising daily administration to such patient of from about 1 to about 100 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.

REFERENCES:
patent: 4877791 (1989-10-01), Sherman
patent: 4923875 (1990-05-01), Frost
Y. Olsson et al., Acta Neurol. Scandinav., 50:611-618, (1974).
D. Johnson et al., Ann. New York Acad. Sci., 1989, 727-728.
C. M. S. Fewtrell et al., J. Physiol., 330:393-411, (1982).
S. K. Kostyk et al., Brain Res., 504:284-288, (1989).
W. I. Rosenblum, Brain Res., 49:75-82, (1973).
K. Sugiyama, Nature, 370:614-615, (1977).
G. N. Dietsch et al., J. Immun., 142:1476-1481, (1989).
E. Orr, Ann. New York Acad. Sci., 1989, 723-726.
Casale et al., J. Aller. Clin. Immunol., 73:775-781, (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treatment for multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment for multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for multiple sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1143879

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.